Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_assertion description "[Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_assertion evidence source_evidence_literature NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_assertion SIO_000772 21892211 NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_assertion wasDerivedFrom befree-20150227 NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_assertion wasGeneratedBy ECO_0000203 NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP841287.RAVH0W0uZD-u2ouNCnCaxFNceMRQCVTXxMr4ApbiBrMy4130_provenance.